Fullscript has partnered with wearable device company ŌURA to bring its biometric insights into Fullscript’s clinical workflow, the companies announced on Monday during the J.P. Morgan Healthcare conference in San Francisco.
Fullscript, based in Ottawa, Ontario, offers a suite of clinical tools to help providers deliver whole-person care, including diagnostics, clinical decision support, supplements and more. It has served over 125,000 providers and 10 million patients.
Finland-based ŌURA, meanwhile, offers a wearable smart ring called the Oura Ring, as well as an accompanying app. The ring provides personalized insights and guidance on sleep, activity, readiness, stress, resilience, women’s health and heart health.
Through the partnership, providers using Fullscript will be able to view patients’ sleep, readiness and activity data from ŌURA — if the patient opts in. This information will be provided alongside medical history and lab diagnostics. Patients will also be able to see their biometric trends from ŌURA, their supplement protocols and lab results all in one system through Fullscript.
“Continuous, longitudinal health signals, like those captured with Oura Ring, are most powerful when they’re connected to real clinical decision-making,” said Dr. Ricky Bloomfield, chief medical officer at Oura, in a statement. “By integrating Oura insights into Fullscript, we’re giving providers a deeper view of how their patients are sleeping, recovering, and responding to daily stressors, so they can spend less time stitching data together and more time delivering proactive, preventive care that benefits individuals, clinicians, and health systems alike.”
This partnership will start rolling out in early 2026. In the second quarter, the Oura Ring will also be available to order on the Fullscript catalog, allowing providers to start recommending the rings to their patients.
This is Fullscript’s first partnership with a wearable device company, and Fullscript says ŌURA was the natural place to start. The collaboration allows providers to more easily make adjustments to care plans.
“I have patients who wear Oura rings and they hand me their phone in the office visit. Well, me cycling through their last 90 days of data doesn’t really provide much insight, where in Fullscript now we’re going to be able to tee that up. I can immediately make the recommendations or adjustments to the plan,” said Dr. Jeffrey Gladd, chief medical officer of Fullscript in an interview.
Fullscript’s president and CFO, Ashley Koch, echoed these comments.
“Our vision at Fullscript is to basically … connect the dots between what the consumer is doing, what are their habits, what are the normal patterns, how do they engage with digital health apps in the consumer setting, and marry that with the clinical workflow for the provider, so that we can unify treatment plans, so that we can monitor the patient over time, so that we can deliver better insights to the provider that are more actionable,” she said.
Credit: PeopleImages, Getty Images
